MORE VIDEOS
探索更多
乳腺癌

下一个

自动播放
Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]
00:01:46
Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]
7 意见 . 11/26/23 administrator
Researchers discover potential key to screening test for endometrial cancer
00:01:46
Researchers discover potential key to screening test for endometrial cancer
8 意见 . 09/30/23 administrator
Magnetic Hyperthermia Therapy as Potential Therapy for Pediatric Ependymomas
00:15:51
Magnetic Hyperthermia Therapy as Potential Therapy for Pediatric Ependymomas
9 意见 . 09/10/23 administrator
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
00:03:06
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
3 意见 . 08/09/23 administrator
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
00:02:51
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
3 意见 . 08/09/23 administrator
The Importance of Collaboration in Treating CTCL (Chapter 7)
00:02:30
The Importance of Collaboration in Treating CTCL (Chapter 7)
4 意见 . 08/09/23 administrator
The CTCL diagnosis journey
00:00:20
The CTCL diagnosis journey
7 意见 . 08/09/23 administrator
Unmet needs for late-stage CTCL
00:01:10
Unmet needs for late-stage CTCL
4 意见 . 08/09/23 administrator
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
00:01:16
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 意见 . 08/09/23 administrator
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
00:01:35
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
4 意见 . 08/09/23 administrator
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
00:08:49
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
12 意见 . 08/09/23 administrator
Pre-clinical activity of tipifarnib in CTCL
00:02:12
Pre-clinical activity of tipifarnib in CTCL
6 意见 . 08/09/23 administrator
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
00:04:47
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
5 意见 . 08/09/23 administrator
CTCL 06 2017
02:28:08
CTCL 06 2017
2 意见 . 08/09/23 administrator
Brentuximab vedotin for CTCL
00:02:30
Brentuximab vedotin for CTCL
3 意见 . 08/09/23 administrator
Clonal evolution in patients with CTCL
00:02:24
Clonal evolution in patients with CTCL
5 意见 . 08/09/23 administrator
RESMAIN: HDAC inhibitor resminostat for CTCL
00:01:23
RESMAIN: HDAC inhibitor resminostat for CTCL
3 意见 . 08/09/23 administrator
Etiopathogenesis of CTCL for dermatology residents I Dr.P.Ram Sushruth
00:13:18
Etiopathogenesis of CTCL for dermatology residents I Dr.P.Ram Sushruth
3 意见 . 08/09/23 administrator
Unmet needs and upcoming therapies in CTCL
00:03:34
Unmet needs and upcoming therapies in CTCL
2 意见 . 08/09/23 administrator

Dr. Ai on Potential With Mogamulizumab in CTCL

3 意见 • 08/09/23
分享
嵌入
administrator
administrator
订户
0

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, speaks to the relevance of mogamulizumab (Poteligeo) in treating Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放

Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]
00:01:46
Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]
7 意见 . 11/26/23 administrator
Researchers discover potential key to screening test for endometrial cancer
00:01:46
Researchers discover potential key to screening test for endometrial cancer
8 意见 . 09/30/23 administrator
Magnetic Hyperthermia Therapy as Potential Therapy for Pediatric Ependymomas
00:15:51
Magnetic Hyperthermia Therapy as Potential Therapy for Pediatric Ependymomas
9 意见 . 09/10/23 administrator
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
00:03:06
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
3 意见 . 08/09/23 administrator
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
00:02:51
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
3 意见 . 08/09/23 administrator
The Importance of Collaboration in Treating CTCL (Chapter 7)
00:02:30
The Importance of Collaboration in Treating CTCL (Chapter 7)
4 意见 . 08/09/23 administrator
The CTCL diagnosis journey
00:00:20
The CTCL diagnosis journey
7 意见 . 08/09/23 administrator
Unmet needs for late-stage CTCL
00:01:10
Unmet needs for late-stage CTCL
4 意见 . 08/09/23 administrator
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
00:01:16
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 意见 . 08/09/23 administrator
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
00:01:35
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
4 意见 . 08/09/23 administrator
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
00:08:49
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
12 意见 . 08/09/23 administrator
Pre-clinical activity of tipifarnib in CTCL
00:02:12
Pre-clinical activity of tipifarnib in CTCL
6 意见 . 08/09/23 administrator
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
00:04:47
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
5 意见 . 08/09/23 administrator
CTCL 06 2017
02:28:08
CTCL 06 2017
2 意见 . 08/09/23 administrator
Brentuximab vedotin for CTCL
00:02:30
Brentuximab vedotin for CTCL
3 意见 . 08/09/23 administrator
Clonal evolution in patients with CTCL
00:02:24
Clonal evolution in patients with CTCL
5 意见 . 08/09/23 administrator
RESMAIN: HDAC inhibitor resminostat for CTCL
00:01:23
RESMAIN: HDAC inhibitor resminostat for CTCL
3 意见 . 08/09/23 administrator
Etiopathogenesis of CTCL for dermatology residents I Dr.P.Ram Sushruth
00:13:18
Etiopathogenesis of CTCL for dermatology residents I Dr.P.Ram Sushruth
3 意见 . 08/09/23 administrator
Unmet needs and upcoming therapies in CTCL
00:03:34
Unmet needs and upcoming therapies in CTCL
2 意见 . 08/09/23 administrator